Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aprajita Jagpal

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drug Safety|February 3, 2018
Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for CliniciansAprajita Jagpal, Jeffrey R Curtis
Rheumatology (Oxford, England)|November 23, 2017
How to use bisphosphonates safely and optimallyAprajita Jagpal, Kenneth G Saag
BMC Rheumatology|March 20, 2019
Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatmentAprajita Jagpal, Iris Navarro-Millán
Proceedings (Baylor University. Medical Center)|August 7, 2019
Severe arthritis and tenosynovitis caused by immune checkpoint blockade therapy with pembrolizumab (anti-PD-1 antibody)Aprajita Jagpal, Gagandeep Choudhary, Jad Chokr
Rheumatology (Oxford, England)|June 6, 2017
More than meets the eye: IgG4-related disease presenting as isolated interstitial lung diseaseAprajita Jagpal, David R Crowe, Joao A de Andrade, et al.
Arthritis Care & Research|November 11, 2018
Screening of Hyperlipidemia Among Patients With Rheumatoid Arthritis in the United StatesIris Navarro-Millán, Shuo Yang, Lang Chen, et al.
BMC Rheumatology|September 14, 2019
Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?Aprajita Jagpal, Ronan O'Beirne, Melanie S Morris, et al.
Rheumatology (Oxford, England)|August 15, 2020
Which factors predict discordance between a patient and physician on a gout flare?Aprajita Jagpal, Elizabeth J Rahn, Amy S Mudano, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug Safety|February 3, 2018
Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for CliniciansAprajita Jagpal, Jeffrey R Curtis
Rheumatology (Oxford, England)|November 23, 2017
How to use bisphosphonates safely and optimallyAprajita Jagpal, Kenneth G Saag
BMC Rheumatology|March 20, 2019
Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatmentAprajita Jagpal, Iris Navarro-Millán
Proceedings (Baylor University. Medical Center)|August 7, 2019
Severe arthritis and tenosynovitis caused by immune checkpoint blockade therapy with pembrolizumab (anti-PD-1 antibody)Aprajita Jagpal, Gagandeep Choudhary, Jad Chokr
Rheumatology (Oxford, England)|June 6, 2017
More than meets the eye: IgG4-related disease presenting as isolated interstitial lung diseaseAprajita Jagpal, David R Crowe, Joao A de Andrade, et al.
Arthritis Care & Research|November 11, 2018
Screening of Hyperlipidemia Among Patients With Rheumatoid Arthritis in the United StatesIris Navarro-Millán, Shuo Yang, Lang Chen, et al.
BMC Rheumatology|September 14, 2019
Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?Aprajita Jagpal, Ronan O'Beirne, Melanie S Morris, et al.
Rheumatology (Oxford, England)|August 15, 2020
Which factors predict discordance between a patient and physician on a gout flare?Aprajita Jagpal, Elizabeth J Rahn, Amy S Mudano, et al.
Pageof 1